Cardiac and arterial interactions in end-stage renal disease

被引:435
作者
London, GM
Guerin, AP
Marchais, SJ
Pannier, B
Safar, ME
Day, M
Metivier, F
机构
[1] INSERM,U337,PARIS,FRANCE
[2] JOHN HUNTER HOSP,DEPT ANAESTHESIA & INTENS CARE,NEWCASTLE,NSW,AUSTRALIA
关键词
D O I
10.1038/ki.1996.355
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although cardiac hypertrophy is a frequent complication of end-stage renal disease (ESRD), relatively little is known about large arterial geometry and function in vivo in these patients, and the relationship between arterial changes and cardiac hypertrophy is unknown. Common carotid artery (CCA) intima-media thickness and internal diameter and left ventricular geometry and function were determined by ultrasound imaging in 70 uncomplicated ESRD patients and in 50 age-, sex-, and blood pressure-matched controls. Arterial distensibility and compliance were determined from simultaneously recorded CCA diameter and stroke changes in diameter and CCA pressure waveforms, obtained by applanation tonometry, and also by the measurement of carotid-femoral pulse wave velocity. Compared with control subjects, ESRD patients had greater left ventricular diameter (P < 0.01), wall thicknesses and mass (P < 0.001), increased CCA diameter (6.25 +/- 0.87 vs 5.55 +/- 0.65 mm; P < 0.001), larger CCA intima-media thickness (777 +/- 115 vs. 678 +/- 105 mu m; P < 0.001) and intima-media cross-sectional area (17.5 +/- 4.5 vs. 13.4 +/- 3.3 mm(2); P < 0.001). In uremic patients, arterial hypertrophy was associated with decreased CCA distensibility (17.8 +/- 8.8 vs. 24.0 +/- 12.7 kPa(-1) . 10(-5); P < 0.001) and compliance (5.15 +/- 2 vs. 6.0 +/- 2.5 m(2) . kPa(-1) . 10(-7); P < 0.05), accelerated carotid-femoral pulse wave velocity (1055 +/- 290 vs. 957 +/- 180 cm/seconds; P < 0.001), early return and increased effect of arterial wave reflections (20.5 +/- 15.4 vs. 9.2 +/- 18.4%; P < 0.001). The latter phenomenons were responsible for increased pulsatile pressure load in CCA (58.3 +/- 21 vs. 48 +/- 17 mm Hg; P < 0.01) and were associated with a decreased subendocardial viability index (157 +/- 31 vs. 173 +/- 30%; P < 0.001). The CCA diameter was correlated with the left ventricular diameter (P < 0.01), and a significant correlations existed between CCA wail thickness or CCA intima-media cross-sectional area and left ventricular wall thicknesses and/or left ventricular mass (P < 0.01). Ln multivariate analysis, these relationships were independent regarding age,sex, blood pressure and body surface area. The presents study documents parallel cardiac and vascular adaptation in ESRD, and demonstrates the potential contribution of structural and functional large artery alterations to the pathogenesis of left ventricular hypertrophy and functional alterations.
引用
收藏
页码:600 / 608
页数:9
相关论文
共 50 条
  • [21] Iron and cardiac disease in the end-stage renal disease setting
    Besarab, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : S18 - S24
  • [22] Combined Cardiac Impairments in End-Stage Renal Disease
    Małgorzata Sobieszczańska
    Krystyna Laszki-Szcząchor
    Pediatric Cardiology, 2012, 33 : 1238 - 1239
  • [23] Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease
    London, Gerard M.
    BLOOD PURIFICATION, 2018, 45 (1-3) : 154 - 158
  • [24] Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
    Esposito, Pasquale
    Verzola, Daniela
    La Porta, Edoardo
    Milanesi, Samantha
    Grignano, Maria Antonietta
    Avella, Alessandro
    Gregorini, Marilena
    Abelli, Massimo
    Ticozzelli, Elena
    Rampino, Teresa
    Garibotto, Giacomo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (10) : 1039 - 1052
  • [25] Arterial calcifications and bone histomorphometry in end-stage renal disease
    London, GM
    Marty, C
    Marchais, SJ
    Guerin, AP
    Metivier, F
    De Vernejoul, MC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (07): : 1943 - 1951
  • [26] Arterial stiffening and vascular calcifications in end-stage renal disease
    Guérin, AP
    London, GM
    Marchais, SJ
    Metivier, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) : 1014 - 1021
  • [27] CARDIAC-HYPERTROPHY AND ARTERIAL ALTERATIONS IN END-STAGE RENAL-DISEASE - HEMODYNAMIC FACTORS
    LONDON, GM
    MARCHAIS, SJ
    GUERIN, AP
    METIVIER, F
    PANNIER, B
    KIDNEY INTERNATIONAL, 1993, 43 : S42 - S49
  • [28] Cardiac troponins: Utility in renal insufficiency and end-stage renal disease
    Watnick, S
    Perazella, MA
    SEMINARS IN DIALYSIS, 2002, 15 (01) : 66 - 70
  • [29] Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
    Blacher, J
    Guerin, AP
    Pannier, B
    Marchais, SJ
    London, GM
    HYPERTENSION, 2001, 38 (04) : 938 - 942
  • [30] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514